Table 5. | Assessment of the risk of bias for included controlled clinical studies |
| Study |
Random sequence generation |
Allocation concealment |
Blinding |
Incomplete outcome data |
Selective reporting |
Other bias |
Summary assessment |
|---|---|---|---|---|---|---|---|
| Tallarico et al. [27] | Low | Low | Low | Low | Low | Low | Low |
| Cardaropoli et al. [29] | Low | Unclear | Unclear | Low | Low | Low | Unclear |
| Barone et al. [30] | Unclear | Low | Low | Low | Low | Low | Low |
| Marconcini et al. [31] | Low | Low | Unclear | Low | Low | Unclear | Low |
| Felice et al. [32] | Low | Unclear | Unclear | Low | Low | High | Unclear |
| Esposito et al. [33] | Low | Low | Low | Low | Low | Unclear | Low |
| Esposito et al. [34] | Low | High | Low | Low | Low | Unclear | Low |
.png)
.png)
.png)
.png)